Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11996 | 30653387 | J Womens Health (Larchmt) | Serum Testosterone Level Within Normal Range Is Positively Associated with Nonalcoholic Fatty Liver Disease in Premenopausal but Not Postmenopausal Women. | 2019 | Details |
| A11997 | 30653341 | Am J Physiol Gastrointest Liver Physiol | Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. | 2019 | Details |
| A11998 | 30652643 | Curr Pharm Des | The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11999 | 30652642 | Curr Pharm Des | Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts. | 2018 | Details |
| A12000 | 30652641 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome. | 2018 | Details |
| A12002 | 30652107 | Microb Cell | Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD. | 2018 | Details |
| A12003 | 30651891 | Genes Nutr | Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study. | 2019 | Details |
| A12004 | 30651350 | J Biol Chem | Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats. | 2019 | Details |
| A12005 | 30649436 | J Clin Endocrinol Metab | Association of Bright Liver With the PNPLA3 I148M Gene Variant in 1-Year-Old Toddlers. | 2019 | Details |
| A12006 | 30648978 | Holist Nurs Pract | Traditional Chinese Medicine and Intestinal Microbiota: A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases. | 2020 | Details |
| A12008 | 30647436 | Eur J Clin Nutr | A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2019 | Details |
| A12009 | 30646922 | Lipids Health Dis | Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis. | 2019 | Details |
| A12010 | 30646522 | Int J Mol Sci | Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. | 2019 | Details |
| A12011 | 30645665 | Internist (Berl) | [New aspects of nonalcoholic steatohepatitis]. | 2019 | Details |
| A12012 | 30643981 | J Gastroenterol | Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science. | 2019 | Details |
| A12013 | 30643537 | Evid Based Complement Alternat Med | Mulberry Fruit Extract Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) through Inhibition of Mitochondrial Oxidative Stress in Rats. | 2018 | Details |
| A12014 | 30642871 | Dis Model Mech | Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity. | 2019 | Details |
| A12016 | 30642126 | Int J Mol Sci | Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A12017 | 30642098 | Microorganisms | Microbial Fermentation of Dietary Protein: An Important Factor in Diet⁻Microbe⁻Host Interaction. | 2019 | Details |
| A12019 | 30641737 | Diabetes Metab Syndr | Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center. | 2018 | Details |
| A12020 | 30641706 | Diabetes Metab Syndr | Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. | 2018 | Details |
| A12021 | 30641412 | Mol Immunol | New Aspect of Liver IL-17+γδ T Cells. | 2019 | Details |
| A12022 | 30640271 | J Pediatr Gastroenterol Nutr | Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States. | 2019 | Details |
| A12023 | 30639779 | Clin Gastroenterol Hepatol | Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12024 | 30639268 | Chem Biol Interact | Chronic intake of moderate fat-enriched diet induces fatty liver and low-grade inflammation without obesity in rabbits. | 2019 | Details |
| A12025 | 30639231 | J Ethnopharmacol | Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial. | 2019 | Details |
| A12026 | 30636945 | J Korean Med Sci | Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies. | 2019 | Details |
| A12027 | 30636282 | Eur J Clin Invest | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. | 2019 | Details |
| A12028 | 30635917 | Br J Pharmacol | Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice. | 2019 | Details |
| A12029 | 30635812 | Obes Surg | Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score. | 2019 | Details |
| A12030 | 30634538 | Molecules | MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease. | 2019 | Details |
| A12031 | 30634482 | J Clin Med | Non-Invasive Assessment Method Using Thoracic-Abdominal Profile Image Acquisition and Mathematical Modeling with Bezier Curves. | 2019 | Details |
| A12032 | 30633176 | Medicine (Baltimore) | A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates. | 2019 | Details |
| A12033 | 30631885 | Singapore Med J | A practical clinical approach to liver fibrosis. | 2018 | Details |
| A12034 | 30631760 | Can J Gastroenterol Hepatol | Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
| A12035 | 30631397 | World J Hepatol | Body mass index and its effects on liver fat content in overweight and obese young adults by proton magnetic resonance spectroscopy technique. | 2018 | Details |
| A12036 | 30630736 | Dig Liver Dis | Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice. | 2018 | Details |
| A12037 | 30630288 | Biomol Ther (Seoul) | Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice. | 2019 | Details |
| A12038 | 30630004 | Life Sci | A maternal high-fat diet may accelerate adipo-immunologic aging in offspring. | 2019 | Details |
| A12039 | 30628769 | ACS Appl Mater Interfaces | Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12040 | 30628563 | Proc Nutr Soc | Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis. | 2019 | Details |
| A12041 | 30627261 | Gastroenterology Res | Steatohepatitic Variant of Hepatocellular Carcinoma: A Focused Review. | 2018 | Details |
| A12042 | 30626749 | JCI Insight | The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity. | 2019 | Details |
| A12043 | 30625517 | Biomed Pharmacother | A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A12044 | 30625508 | Exp Clin Endocrinol Diabetes | Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12045 | 30625487 | Dig Dis | Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12046 | 30625377 | Toxicol Lett | Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. | 2019 | Details |
| A12047 | 30625307 | Cell Metab | NASH and HCC Are Driven by Different Signaling Pathways with a Common Regulator. | 2019 | Details |
| A12048 | 30625285 | Annu Rev Pharmacol Toxicol | Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. | 2019 | Details |
| A12049 | 30623852 | J Nutr Biochem | A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study. | 2018 | Details |
| A12050 | 30623792 | Biomaterials | Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance. | 2019 | Details |
| A12051 | 30622377 | World J Gastroenterol | Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. | 2018 | Details |
| A12052 | 30622370 | World J Gastroenterol | Role of cenicriviroc in the management of nonalcoholic fatty liver disease. | 2018 | Details |
| A12053 | 30621707 | Lipids Health Dis | Plasma lipidomic signatures of spontaneous obese rhesus monkeys. | 2019 | Details |
| A12054 | 30621686 | Lipids Health Dis | Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. | 2019 | Details |
| A12055 | 30621142 | Nutrients | Effect of Wakame and Carob Pod Snacks on Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A12056 | 30619996 | Hepatol Commun | Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population. | 2018 | Details |
| A12057 | 30619993 | Hepatol Commun | Childhood Fructoholism and Fructoholic Liver Disease. | 2018 | Details |
| A12058 | 30619992 | Hepatol Commun | Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12059 | 30619479 | Front Genet | Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study. | 2018 | Details |
| A12060 | 30619336 | Front Immunol | Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis. | 2018 | Details |
| A12061 | 30618824 | Front Physiol | Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12062 | 30618753 | Front Pharmacol | Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy. | 2018 | Details |
| A12063 | 30618733 | Front Pharmacol | Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet. | 2018 | Details |
| A12064 | 30618391 | Georgian Med News | [ANTHROPOMETRIC CHARACTERISTICS AND PARAMETERS OF LIPID-CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION DEPENDING ON THE DEGREE OF HEPATIC STEATOSIS]. | 2018 | Details |
| A12065 | 30617917 | Obes Surg | Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12066 | 30617773 | J Gastrointest Surg | Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC. | 2019 | Details |
| A12067 | 30617744 | Pflugers Arch | Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice. | 2019 | Details |
| A12068 | 30616887 | Biochem Biophys Res Commun | Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. | 2019 | Details |
| A12069 | 30616587 | BMC Complement Altern Med | The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules. | 2019 | Details |
| A12070 | 30616027 | Clin Gastroenterol Hepatol | Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. | 2019 | Details |
| A12071 | 30615941 | Metab Eng | Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function. | 2019 | Details |
| A12074 | 30614770 | Metab Syndr Relat Disord | Pubertal Status and Gonadal Functions in Obese Boys with Fatty Liver. | 2019 | Details |
| A12075 | 30613527 | J Family Med Prim Care | Incidence of nonalcoholic fatty liver disease in patients undergoing laparoscopic cholecystectomy. | 2022 | Details |
| A12076 | 30611993 | Biomed Pharmacother | Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. | 2019 | Details |
| A12077 | 30611723 | Toxicol Appl Pharmacol | Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells. | 2019 | Details |
| A12078 | 30611703 | Alcohol | Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue. | 2019 | Details |
| A12080 | 30611282 | Lipids Health Dis | Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet. | 2019 | Details |
| A12081 | 30610213 | Eur J Clin Nutr | The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A12082 | 30609782 | Nutrients | Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12083 | 30609663 | Cells | Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease. | 2019 | Details |
| A12084 | 30609189 | Liver Transpl | Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. | 2019 | Details |
| A12085 | 30609187 | Liver Transpl | Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. | 2019 | Details |
| A12086 | 30608932 | PLoS One | High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. | 2019 | Details |
| A12087 | 30607807 | Infect Dis Ther | A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? | 2019 | Details |
| A12088 | 30607652 | Clin Rheumatol | Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. | 2019 | Details |
| A12089 | 30606929 | Yakugaku Zasshi | [A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics]. | 2019 | Details |
| A12090 | 30606928 | Yakugaku Zasshi | [The Investigation of Genes, Using an Improved Adenovirus Vector, and Food for the Treatment and Prevention of Type 2 Diabetes Mellitus]. | 2019 | Details |
| A12091 | 30605949 | Zhonghua Nei Ke Za Zhi | [Glucagon-like peptide-1 regulates lipid metabolism in hepatocytes through Foxo1/3]. | 2019 | Details |
| A12092 | 30605883 | Redox Biol | Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. | 2018 | Details |
| A12093 | 30605818 | Environ Pollut | Effects of triphenyl phosphate exposure during fetal development on obesity and metabolic dysfunctions in adult mice: Impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A12094 | 30605676 | Cell Rep | Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD. | 2019 | Details |
| A12095 | 30605011 | Am J Physiol Gastrointest Liver Physiol | Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice. | 2019 | Details |
| A12096 | 30604460 | Diabetes Metab Res Rev | Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease. | 2019 | Details |
| A12098 | 30603757 | Mol Omics | Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD. | 2019 | Details |
| A12099 | 30603617 | J Med Signals Sens | Noninvasive Quantification of Liver Fat Content by Different Gradient Echo Magnetic Resonance Imaging Sequences in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A12100 | 30602434 | J Med Internet Res | Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. | 2019 | Details |
| A12101 | 30602382 | J Transl Med | Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A12102 | 30601337 | Eur J Gastroenterol Hepatol | Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2019 | Details |
| A12103 | 30601174 | Curr Opin Clin Nutr Metab Care | Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? | 2019 | Details |